Drawing for SPACEIQ

USPTO serial 98486069

SPACEIQ

Reviewed by CopyMark Law Group

Reg. 8296752Status 700Registered
Filing date
Status date
Registration date
Jun 9, 2026
Examiner
PORTARO, ALEXANDRA J
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SPACEIQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Victoria D Summerfield

Victoria D Summerfield Troutman Pepper501 Grant Street, Suite 300Pittsburgh, PA 15219United States

Goods and services

ClassDescriptionStatusFirst use
042Software as a service (SAAS) services featuring web based pathology software, namely, web based image analysis software for use in the field of pathology; Software as a service (SAAS) services featuring software for use in the field of pathology, namely, software that defines the spatial relationships between cells and molecules within tissue microenvironments to aid in the interpretation of patient tissue samples, predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics; Software as a service (SAAS) services featuring software for performing image analysis in the field of pathology, namely, in connection with transmitted light microscopy and fluorescence microscopy; Software as a service (SAAS) services featuring software for reviewing and managing images and for digital pathology image management; Software as a service (SAAS) services featuring software for use in cancer diagnosis, namely, software to predict metastatic potential in primary solid tumors; Software as a service (SAAS) services featuring web based software for viewing, annotating, analyzing, and scoring digital slides, for consolidating case information, a score, results, a diagnosis, comments, and digital images into a pathology case report, for generating, exporting, and printing pathology case reports, and for providing audit trials in the field of pathology; Software as a service (SAAS) services featuring web based software for remotely accessing pathology images, for remotely accessing pathology images and metadata, and for creating, assigning, and managing pathology cases; Providing an online searchable database featuring images for evaluating machine learning algorithms for computational pathology, for scientific and medical research purposes; medical research, namely, pathology evaluations utilizing image analysis algorithms; Medical and scientific research in the field of cancer treatment and diagnosis and consultation related thereto; medical and scientific research in the field of medical imaging and consultation related thereto; Software as a service (SAAS) services featuring computer software for use in image analysis of digital images of tissue samples acquired by optical microscopy; Software as a service (SAAS) services featuring computer software for creating tissue-based image analysis algorithms to predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics; Software as a service (SAAS) services featuring data processing software for tissue-based image analysis using algorithms; Software as a service, (SAAS) services featuring data processing software for tissue-based image analysis using algorithms to predict patient outcomes, provide personalized therapeutic strategies, and develop diagnosticsACTIVEMar 18, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 9, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 9, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 16, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 16, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 12, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 6, 2026IUAFUSE AMENDMENT FILED—
Jan 6, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 18, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 17, 2025EX1GSOU EXTENSION 1 GRANTED—
Jun 17, 2025EXT1SOU EXTENSION 1 FILED—
Jun 17, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 26, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 26, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 20, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 29, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 18, 2024DOCKASSIGNED TO EXAMINER—
Sep 11, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 15, 2024TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Apr 15, 2024PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 5, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance